Cargando…
Clostridium butyricum enhances colonization resistance against Clostridioides difficile by metabolic and immune modulation
Clostridioides difficile infection (CDI) represents the leading cause of nosocomial diarrhea worldwide and is associated with gut dysbiosis and intestinal damage. Clostridium butyricum MIYAIRI 588 (CBM 588) contributes significantly to reduce epithelial damage. However, the impacts of CBM 588 on ant...
Autores principales: | Hagihara, Mao, Ariyoshi, Tadashi, Kuroki, Yasutoshi, Eguchi, Shuhei, Higashi, Seiya, Mori, Takeshi, Nonogaki, Tsunemasa, Iwasaki, Kenta, Yamashita, Makoto, Asai, Nobuhiro, Koizumi, Yusuke, Oka, Kentaro, Takahashi, Motomichi, Yamagishi, Yuka, Mikamo, Hiroshige |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298451/ https://www.ncbi.nlm.nih.gov/pubmed/34294848 http://dx.doi.org/10.1038/s41598-021-94572-z |
Ejemplares similares
-
Clostridium butyricum Modulates the Microbiome to Protect Intestinal Barrier Function in Mice with Antibiotic-Induced Dysbiosis
por: Hagihara, Mao, et al.
Publicado: (2019) -
Clostridium butyricum MIYAIRI 588-Induced Protectin D1 Has an Anti-inflammatory Effect on Antibiotic-Induced Intestinal Disorder
por: Ariyoshi, Tadashi, et al.
Publicado: (2020) -
Effect of Clostridium butyricum on Gastrointestinal Infections
por: Ariyoshi, Tadashi, et al.
Publicado: (2022) -
Comparison of clinical severity, genotype and toxin gene expression of binary toxin-producing Clostridioides difficile clinical isolates in Japan
por: Matsumoto, Asami, et al.
Publicado: (2022) -
Clostridium butyricum MIYAIRI 588 Modifies Bacterial Composition under Antibiotic-Induced Dysbiosis for the Activation of Interactions via Lipid Metabolism between the Gut Microbiome and the Host
por: Ariyoshi, Tadashi, et al.
Publicado: (2021)